BridgeMD
New treatment option for Paranoia
Official title Acceptability and Feasibility of a Brief Paranoia Intervention.
ClinicalTrials.gov ID: NCT07350954
What this study is testing
- What it's testing
- The goal of this feasibility and acceptability trial is to test whether a new brief talking therapy can be successfully provided to and is suitable for adolescents (16-18) who are seeking help from Child and Adolescent Mental Health Services (CAMHS). The main research question for the current study is: Is it feasible and acceptable to offer a brief values-based (helping young people identify what matters most to them) and imagery (using imagination to visualise positive experiences) intervention for adolescents experiencing paranoia in CAMHS?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 18
You may be able to join if
- Aged 16-18
- Seeking help from a Child and Adolescent Mental Health Service (CAMHS)
- A score ≥ 11 on the R-GPTS (Scale B)
- Sufficient understanding of English
- Capacity to consent, as assessed during the initial interview
You likely can't join if
- Severe comorbid diagnoses apparent at the initial assessment (e.g., a primary alcohol or substance dependence issue measured using standardised...
- The presence of a developmental disability or cognitive impairment that would interfere with participation.
- Concurrent participation in another psychological therapy
- High levels of current risk (e.g., significant and immediate concerns about the young person's safety, such as suicidal intent).
See the full eligibility criteria
- Aged 16-18
- Seeking help from a Child and Adolescent Mental Health Service (CAMHS)
- A score ≥ 11 on the R-GPTS (Scale B)
- Sufficient understanding of English
- Capacity to consent, as assessed during the initial interview
- Wanting support with paranoia
- Low- moderate mental health risks (emotional difficulties that impact functioning, but no immediate risk to safety e.g., no suicidal intent).
- Severe comorbid diagnoses apparent at the initial assessment (e.g., a primary alcohol or substance dependence issue measured using standardised assessments)
- The presence of a developmental disability or cognitive impairment that would interfere with participation.
- Concurrent participation in another psychological therapy
- High levels of current risk (e.g., significant and immediate concerns about the young person's safety, such as suicidal intent).
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 18 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.